There's no foolproof way to know the future for Exactech (NAS: EXAC) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock ...

The FDA sent the warning letter after an inspection of Exactech’s Sarasota, Florida, facility in July. At the time of the ...

In March, Exactech told customers it would recall shoulder devices to “eliminate confusion and concern in the market” following the FDA’s safety warning. Exactech began recalling some devices in 2021 ...

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (NAS: EXAC) , which designs and manufactures bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, said that ...

The US Patent and Trademark Office (USPTO) has issued patent 12,239,384 for Exactech’s Newton soft tissue balancing technology. This patent is part of a series of applications aimed at advancing the ...

Margins matter. The more Exactech (Nasdaq: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

The FDA reminded healthcare providers and patients on Thursday that several Exactech joint replacement devices packaged in defective bags should be closely monitored for device wear or failure. Many ...

Exactech Inc. (Nasdaq: EXAC) has agreed to acquire Altiva Corp., a Charlotte, N.C.-based maker of spinal implant devices and related products. The deal represents Exactech's decision to exercise a ...

Margins matter. The more Exactech (Nasdaq: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

Medical devicemaker Exactech agreed to pay $8 million to settle allegations that it knowingly marketed and sold defective components within its line of Optetrak total knee systems, which have been ...